期刊文献+

透析及非透析终末期肾脏病患者血管钙化情况和影响因素分析

Clinical characteristics and influencing factors of vascular calcification in dialysis and non-dialysis patients with end stage renal disease
下载PDF
导出
摘要 目的:评估透析及非透析终末期肾脏病(ESRD)患者血管钙化情况并探讨其影响因素。方法:纳入我院2019年12月至2020年12月病情稳定的ESRD患者191例,分为透析组74例、非透析组117例,比较两组患者的血管钙化发生率及钙化严重程度,分析血管钙化的影响因素。结果:透析组血管钙化发生率(56.8%)显著高于非透析组(41.9%)。logistic回归分析结果表明高龄和空腹血糖升高是非透析ESRD患者血管钙化的危险因素,高龄和高血压是透析ESRD患者发生血管钙化的危险因素(P<0.05)。结论:透析和非透析ESRD患者血管钙化的特征和影响因素存在差异,应该针对其特点进一步优化管理,实现个体化管控。 Objective:To evaluate the vascular calcification in dialysis and non-dialysis patients with end-stage renal disease(ESRD),and to explore its influencing factors.Methods:191 ESRD patients with stable disease in our hospital from September 2019 to September 2020 were divided into dialysis group(n=74)and non-dialysis group(n=117).Results:The incidence of vascular calcification in dialysis group(56.8%)was significantly higher than that in non-dialysis group(41.9%).The results of logistic regression analysis indicated that advanced age and fasting blood glucose were the risk factors of vascular calcification in non-dialysis ESRD patients,and advanced age and hypertension were the risk factors of vascular calcification in dialysis ESRD patients(P<0.05).Conclusion:There are differences in the characteristics and influencing factors of vascular calcification between dialysis and non-dialysis ESRD patients.Management should be further optimized according to their characteristics to achieve individualized management and control.
作者 杨星梦 马晓迎 生玉平 徐海平 张浩然 王娜 孙福云 Yang Xingmeng;Ma Xiaoying;Sheng Yuping;Xu Haiping;Zhang Haoran;Wang Na;Sun Fuyun(Second Department of Nephrology,Cangzhou Central Hospital,Cangzhou,Hebei 061000,China)
出处 《现代临床医学》 2022年第4期249-252,256,共5页 Journal of Modern Clinical Medicine
基金 河北省沧州市重点研发计划指导项目(204106081)。
关键词 终末期肾脏病 透析 血管钙化 end-stage renal disease dialysis vascular calcification
  • 相关文献

参考文献1

二级参考文献20

  • 1常明,刘红,刘书馨,腾兰波,王志宏,刘焱,赵华,付瑶,王伟.尿毒症患者血管钙化及相关因素的研究[J].中华肾脏病杂志,2006,22(9):578-579. 被引量:18
  • 2Rask - Madsen C, King GL. Factors that protect the diabeticvasculature. Nat Med, 2010,16: 40-41.
  • 3Rennenberg R,Kessels A, Schurgers LJ, et al. Vascularcalcifications as a marker of increased cardiovascular risk: ameta-analysis. Vase Health Risk Manag, 2009, 5: 185-197.
  • 4Ford ES, Zhao G, Li C. Pre - diabetes and the risk forcardiovascular disease: a systematic review of the evidence. JAm Coll Cardiol, 2010,55: 1310-1317.
  • 5Tang R,Li Q, Lv L,et al. Angiotensin II mediates the highglucose - induced endothelial - to - mesenchymal transition inhuman aortic endothelial cells. Cardiovasc Diabetol, 2010,9:31.
  • 6Tang RN, Lv LL, Zhang JD,et al. Effects of angiotensin IIreceptor blocker on myocardial endothelial - to - mesenchymaltransition in diabetic rats. Int J Cardiol, 2013,162: 92-99.
  • 7Persy V, D'Haese P. Vascular calcification and bone disease:the calcification paradox. Cell, 2009, 15: 405-416.
  • 8Lehto S, Niskanen L, Suhonen M, et al. Medial arterycalcification, a neglected harbinger of cardiovascularcomplications in non - insulin - dependent diabetes mellitus.Arterioscler Thromb Vase Biol, 1996, 16: 978-983.
  • 9Drueke TB, Massy ZA. Medial or intimal calcification in CKD -does it matter. Nat Rev Nephrol, 2011, 7: 250-251.
  • 10Neven E, De Schutter TM, De Broe ME, et al. Cell biologicaland physicochemical aspects of arterial calcification. KidneyInt, 2011,79: 1166-1177.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部